American National Registered Investment Advisor’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
American National Registered Investment Advisor's BMY Position: Q1 2022 in Review
American National Registered Investment Advisor reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2022, selling an estimated $19.6K and leaving 17,628 shares worth $1.29M. The position accounts for 0.46% of the portfolio, ranked #59.
American National Registered Investment Advisor first reported a position in BMY in Q3 2019 and has held it in 11 quarters since. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- American National Registered Investment Advisor held 17,628 shares of Bristol-Myers Squibb worth $1.29M as of Q1 2022.
- American National Registered Investment Advisor sold 292 Bristol-Myers Squibb shares in Q1 2022, an estimated $19.6K.
- Bristol-Myers Squibb made up 0.46% of American National Registered Investment Advisor's portfolio in Q1 2022, its #59 holding.
- American National Registered Investment Advisor first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 11 quarters since.
- 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on American National Registered Investment Advisor's 13F filing for Q1 2022, filed 13 May 2022.